RT Chlebowski, SL Hendrix, RD Langer, ML … - Jama, 2003 - Am Med Assoc Context The Women's Health Initiative trial of combined estrogen plus progestin
was stopped early when overall health risks, including invasive breast cancer,
exceeded benefits. Outstanding issues not previously addressed include ... Cited by 732 - Related articles - BL Direct - All 8 versions
- ►oxfordjournals.org RK Ross, A Paganini-Hill, PC Wan, MC Pike - JNCI Journal of the National Cancer Institute, 2000 - jnci.oxfordjournals.org BACKGROUND: Hormone replacement therapy (HRT) given as unopposed estrogen
replacement therapy (ERT) gained widespread popularity in the United States in
the 1960s and 1970s. Recent prescribing practices have favored combination ... Cited by 706 - Related articles - BL Direct - All 30 versions
- ►ahrq.gov [PDF] LL Humphrey, M Helfand, BKS Chan, SH … - Annals of Internal Medicine, 2002 - Am Coll Physicians Study Selection: Eight randomized, controlled trials of mammography and 2 trials
evaluating breast self-examination were included. One hundred fifty-four
publications of the results of these trials, as well as selected articles ... Cited by 565 - Related articles - BL Direct - All 10 versions
M Clemons, P Goss - The New England journal of medicine, 2001 - nejm.highwire.org Experimental data strongly suggest that estrogens have a role in the development
and growth of breast cancer. 2 Although the exact mechanisms remain to be fully
elucidated, the alkylation of cellular molecules and the generation of ... Cited by 455 - Related articles - BL Direct - All 8 versions
RT Chlebowski, SL Hendrix, RD Langer, ML … - JAMA, 2003 - menopausaitaliana.it Rowan T. Chlebowski, MD, PhD Susan L. Hendrix, DO Robert D. Langer, MD, MPH
Marcia L. Stefanick, PhD Margery Gass, MD Dorothy Lane, MD, MPH Rebecca J.
Rodabough, MS Mary Ann Gilligan, MD, MPH Michele G. Cyr, MD Cynthia A. ... Cited by 284 - Related articles - All 22 versions
- ►nutrition.org MJ Messina, CL Loprinzi - Journal of Nutrition, 2001 - Am Soc Nutrition A variety of health benefits, including protection against breast cancer, have
been attributed to soy food consumption, primarily because of the soybean
isoflavones (genistein, daidzein, glycitein). Isoflavones are considered to ... Cited by 228 - Related articles - BL Direct - All 6 versions
ML Stefanick, GL Anderson, KL Margolis, SL … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 214 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org GA Greendale, BA Reboussin, S Slone, C … - JNCI Journal of the National Cancer Institute, 2003 - jnci.oxfordjournals.org Background: Mammographic density is an independent risk factor for breast
cancer. Postmenopausal hormone use is associated with an increase in
mammographic density, but the magnitude of the density increase is unknown. ... Cited by 208 - Related articles - BL Direct - All 7 versions
- ►aacrjournals.org C Byrne, GA Colditz, WC Willett, FE Speizer, … - Cancer research, 2000 - AACR Insulin-like growth factors (IGFs) and insulin-like growth factor-binding
proteins (IGFBPs) play a role in the normal development of breast tissue and
possibly in the etiology of breast cancer. Breast density is one of the ... Cited by 165 - Related articles - BL Direct - All 6 versions
